Target intelligence / Profile preview

RAS GTPase Family (RAS)

Target
RAS
Molecular classification
Small GTPase, G protein
01

Overview

The RAS protein family consists of small GTPases that act as molecular switches in cell signaling pathways, controlling processes such as cell growth, differentiation, and survival. Mutant forms of RAS proteins are among the most common oncogenic drivers in human cancers. The three main RAS genes in humans are KRAS, NRAS, and HRAS. They cycle between an inactive GDP-bound state and an active GTP-bound state, activating downstream signaling pathways when GTP-bound. Oncogenic mutations, frequently found at codons 12, 13, and 61, impair GTPase activity, resulting in constitutive activation and uncontrolled cell proliferation.

Other names
Kirsten rat sarcoma viral oncogene homologKRASNeuroblastoma RAS viral oncogene homologNRASHarvey rat sarcoma viral oncogene homologHRASK-Ras4AK-Ras4B
02

Mechanism of action

Inhibition of mutant RAS protein activity, disruption of RAS interaction with downstream effectors, inhibition of RAS post-translational modifications

03

Biological functions

Signal transductionCell proliferationCell growthCell differentiationCell survivalRegulation of gene expressionActin cytoskeleton organization
04

Disease associations

Cancer
05

Safety considerations

Acquired resistanceOff-target effectsLimited efficacy in RAS-driven cancers beyond specific mutations (e.g., KRAS G12C)Development of alternative signaling pathways
06

Interacting drugs

KRAS(G12C) inhibitors (e.g., Sotorasib, Adagrasib)
07

Biomarkers

KRAS mutation status (e.g., G12C, G12D, G12V)NRAS mutation status (e.g., Q61)HRAS mutation statusExpression levels of RAS pathway components (e.g., pERK, pAKT)

Beyond the preview

Go deeper on RAS GTPase Family (RAS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RAS GTPase Family (RAS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call